Income Statement (TTM)
iX Biopharma Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 2 | 2 | 2 | 8 | 14 | 14 | 14 | 9 | 4 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 8 |
| Change (%) | 18.83 | 7.36 | 6.86 | 354.01 | 77.97 | 1.03 | 1.02 | -37.03 | -58.80 | 29.20 | 22.60 | 1.22 | 1.20 | -0.81 | -0.82 | 8.73 | 8.03 | 5.48 | 5.19 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 |
| Change (%) | 9.32 | 6.87 | 6.43 | 1.69 | 1.66 | -2.25 | -2.30 | 13.79 | 12.12 | 17.06 | 14.57 | 6.16 | 5.81 | 10.84 | 9.78 | 8.18 | 7.56 | 0.11 | 0.11 | |
| % of Revenue | 133.63 | 122.95 | 122.38 | 121.89 | 27.30 | 15.60 | 15.09 | 14.59 | 26.37 | 71.77 | 65.02 | 60.76 | 63.73 | 66.63 | 74.46 | 82.41 | 81.99 | 81.63 | 77.48 | 73.74 |
| Gross Operating Profit | -0 | -0 | -0 | -0 | 6 | 12 | 12 | 12 | 7 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 2 |
| Change (%) | -18.93 | 4.73 | 4.51 | -1,607.72 | 106.63 | 1.63 | 1.61 | -45.71 | -84.20 | 60.06 | 37.52 | -6.44 | -6.89 | -24.07 | -31.70 | 11.35 | 10.20 | 29.32 | 22.67 | |
| % of Revenue | -33.63 | -22.95 | -22.38 | -21.89 | 72.70 | 84.40 | 84.91 | 85.41 | 73.63 | 28.23 | 34.98 | 39.24 | 36.27 | 33.37 | 25.54 | 17.59 | 18.01 | 18.37 | 22.52 | 26.26 |
| SG&A | 8 | 8 | 8 | 8 | 9 | 10 | 10 | 9 | 9 | 9 | 9 | 9 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Change (%) | -1.16 | 0.91 | 0.91 | 7.51 | 6.98 | -0.47 | -0.47 | -4.58 | -4.80 | 2.64 | 2.57 | -8.65 | -9.47 | -4.45 | -4.66 | 3.10 | 3.00 | -3.80 | -3.95 | |
| % of Revenue | 644.30 | 535.90 | 503.70 | 475.64 | 112.63 | 67.70 | 66.70 | 65.72 | 99.59 | 230.14 | 182.82 | 152.95 | 138.04 | 123.48 | 118.94 | 114.33 | 108.40 | 103.36 | 94.26 | 86.07 |
| R&D | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Change (%) | 5.08 | 3.80 | 3.66 | -1.89 | -1.93 | -5.88 | -6.25 | 13.49 | 11.88 | -2.38 | -2.44 | -16.56 | -19.85 | -4.14 | -4.31 | -1.59 | -1.62 | -1.04 | -1.06 | |
| % of Revenue | 189.80 | 167.85 | 162.28 | 157.42 | 34.02 | 18.74 | 17.46 | 16.21 | 29.21 | 79.32 | 59.93 | 47.69 | 39.31 | 31.14 | 30.09 | 29.03 | 26.28 | 23.93 | 22.45 | 21.11 |
| OpEx | 12 | 13 | 13 | 13 | 14 | 14 | 14 | 14 | 14 | 14 | 15 | 15 | 14 | 13 | 13 | 13 | 14 | 15 | 14 | 14 |
| Change (%) | 1.51 | 2.39 | 2.33 | 4.61 | 4.40 | -1.73 | -1.76 | 1.23 | 1.22 | 4.31 | 4.13 | -6.65 | -7.12 | 0.20 | 0.20 | 4.35 | 4.17 | -1.96 | -1.99 | |
| % of Revenue | 967.73 | 826.69 | 788.36 | 754.96 | 173.95 | 102.04 | 99.25 | 96.52 | 155.16 | 381.22 | 307.78 | 261.41 | 241.09 | 221.25 | 223.49 | 225.78 | 216.67 | 208.91 | 194.19 | 180.92 |
| Operating Income | -11 | -11 | -11 | -11 | -6 | -0 | 0 | 1 | -5 | -10 | -10 | -10 | -8 | -7 | -7 | -7 | -8 | -8 | -7 | -6 |
| Change (%) | -0.49 | 1.70 | 1.67 | -48.74 | -95.08 | -136.98 | 370.42 | -1,097.70 | 110.02 | -4.54 | -4.76 | -11.53 | -13.03 | 1.03 | 1.02 | 0.86 | 0.85 | -8.78 | -9.63 | |
| % of Revenue | -867.73 | -726.69 | -688.36 | -654.96 | -73.95 | -2.04 | 0.75 | 3.48 | -55.16 | -281.22 | -207.78 | -161.41 | -141.09 | -121.25 | -123.49 | -125.78 | -116.67 | -108.91 | -94.19 | -80.92 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -7.37 | -6.72 | -7.20 | 6.32 | 5.95 | 1.53 | 1.51 | 3.47 | 3.35 | 12.73 | 11.29 | 31.00 | 23.66 | 0.34 | 0.34 | -16.74 | -20.11 | 4.59 | 4.39 | |
| % of Revenue | -16.95 | -13.21 | -11.48 | -9.97 | -2.34 | -1.39 | -1.40 | -1.40 | -2.31 | -5.79 | -5.05 | -4.58 | -5.93 | -7.25 | -7.33 | -7.42 | -5.68 | -4.20 | -4.16 | -4.13 |
| Net Income | -9 | -8 | -8 | -8 | -5 | -2 | -3 | -5 | -10 | -16 | -13 | -10 | -10 | -10 | -10 | -11 | -10 | -10 | -10 | -10 |
| Change (%) | -11.84 | 4.55 | 4.35 | -39.32 | -64.80 | 80.70 | 44.66 | 119.74 | 54.49 | -19.20 | -23.76 | -0.10 | -0.10 | 6.25 | 5.88 | -5.00 | -5.26 | 2.19 | 2.15 | |
| % of Revenue | -668.79 | -496.19 | -483.19 | -471.86 | -63.07 | -12.48 | -22.31 | -31.95 | -111.50 | -418.14 | -261.50 | -162.61 | -160.48 | -158.41 | -169.68 | -181.14 | -158.26 | -138.79 | -134.46 | -130.57 |
Source: Capital IQ
